scispace - formally typeset
P

Paul Milligan

Researcher at University of London

Publications -  196
Citations -  11162

Paul Milligan is an academic researcher from University of London. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 59, co-authored 190 publications receiving 10174 citations. Previous affiliations of Paul Milligan include University of Liverpool & University of Salford.

Papers
More filters
Journal ArticleDOI

Tsetse-trypanosomiasis challenge to village N'Dama cattle in The Gambia: field assessments of spatial and temporal patterns of tsetse-cattle contact and the risk of trypanosomiasis infection.

TL;DR: This work has studied spatial distribution of herds of cattle in relation to tsetse in The Gambia and calculated an index of challenge based on the ratio of vectors to hosts over the livestock ranging area that is strongly correlated with estimates of the force of infection calculated from the incidence of infection in susceptible zebu.
Journal ArticleDOI

Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal

TL;DR: The sensitivity of P. falciparum to SMC drugs should be regularly monitored in areas deploying this intervention, as the prevalence of genotypes associated with resistance to either SP or AQ was lower in SMC areas due to the reduced number of parasitaemia individuals.
Journal ArticleDOI

Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children

TL;DR: Simple amendments to current AQ dosing schedules based on the child's age could substantially increase dosing accuracy and thus improve the tolerability of IPTc using SP-amodiaquine in situations where weighing the child is impractical.
Journal ArticleDOI

Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials

TL;DR: This analysis supports the WHO recommendation for coadministration of IPTi with sulfadoxine-pyrimethamine to infants at the time of the second and third doses of DTP and measles vaccination, in areas of sub-Saharan Africa with moderate to high malaria transmission and where malaria parasites are sensitive to these drugs.
Journal ArticleDOI

Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis.

TL;DR: In this article, a cost-effectiveness and cost-savings analysis of a large-scale, multi-country seasonal malaria chemoprevention (SMC) campaign with sulfadoxine-pyrimethamine plus amodiaquine for children younger than 5 years in seven countries in the Sahel subregion (Burkina Faso, Chad, Guinea, Mali, Niger, Nigeria, and The Gambia) in 2016 is presented.